NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cybin Inc (NEO: CYBN)

 
CYBN Technical Analysis
4
As on 26th Feb 2026 CYBN STOCK Price closed @ 10.50 and we RECOMMEND Sell for LONG-TERM with Stoploss of 10.81 & Strong Sell for SHORT-TERM with Stoploss of 13.80 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CYBNSTOCK Price

Open 10.75 Change Price %
High 10.75 1 Day 2.41 29.79
Low 10.02 1 Week -0.69 -6.17
Close 10.50 1 Month 2.52 31.58
Volume 9083 1 Year -4.05 -27.84
52 Week High 15.05 | 52 Week Low 6.95
 
NEO Canada Most Active Stocks
FH 0.01 -50.00%
CCHW 0.51 6.25%
CCHW 0.51 6.25%
GRAM-U 0.32 6.67%
MEDV 0.03 50.00%
MEDI 0.01 -50.00%
MMED 14.90 9.48%
ABXX 45.00 -0.22%
MLC 2.70 0.00%
SLVE 14.89 0.27%
 
NEO Canada Top Gainers Stocks
MEDV 0.03 50.00%
CYBN 10.50 29.79%
CYBN 10.50 29.79%
MMED 14.90 9.48%
FGX 6.20 8.58%
FGX 6.20 8.58%
GRAM-U 0.32 6.67%
CCHW 0.51 6.25%
CCHW 0.51 6.25%
GLDE 17.14 1.72%
 
NEO Canada Top Losers Stocks
MEDI 0.01 -50.00%
MEDI 0.01 -50.00%
FH 0.01 -50.00%
REM 18.35 -1.08%
REM 18.35 -1.08%
REM 18.35 -1.08%
RPU-U 15.26 -0.97%
ABXX 45.00 -0.22%
 
 
CYBN
Daily Charts
CYBN
Intraday Charts
Whats New @
Bazaartrend
CYBN
Free Analysis
 
CYBN Important Levels Intraday
RESISTANCE11.91
RESISTANCE11.46
RESISTANCE11.18
RESISTANCE10.90
SUPPORT10.10
SUPPORT9.82
SUPPORT9.54
SUPPORT9.09
 
CYBN Forecast March 2026
4th UP Forecast15.93
3rd UP Forecast14.19
2nd UP Forecast13.11
1st UP Forecast12.04
1st DOWN Forecast8.96
2nd DOWN Forecast7.89
3rd DOWN Forecast6.81
4th DOWN Forecast5.07
 
CYBN Weekly Forecast
4th UP Forecast13.95
3rd UP Forecast12.84
2nd UP Forecast12.16
1st UP Forecast11.48
1st DOWN Forecast9.52
2nd DOWN Forecast8.84
3rd DOWN Forecast8.16
4th DOWN Forecast7.05
 
CYBN Forecast2026
4th UP Forecast27.07
3rd UP Forecast21.76
2nd UP Forecast18.47
1st UP Forecast15.19
1st DOWN Forecast5.81
2nd DOWN Forecast2.53
3rd DOWN Forecast-0.76
4th DOWN Forecast-6.07
 
 
CYBN Other Details
Segment EQ
Market Capital 380611200.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CYBN Address
CYBN
 
CYBN Latest News
 
Your Comments and Response on Cybin Inc
 
CYBN Business Profile
Cybin Inc., a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.S., and Natures Journey. The Serenity Life and Cybin U.S. segment engages in the research and development of psychedelic pharmaceutical products. The Natures Journey segment focuses on non-psychedelic medicinal mushroom nutraceutical products. It develops CYB001, a drug candidate that is in phase IIa/b for major depressive disorder; CYB003, a deuterated tryptamine preclinical program to treat alcohol use disorder; CYB004, a deuterated tryptamine preclinical program for therapy resistant psychiatric disorder; and CYB005, a phenethylamine preclinical program for psychiatry and neurology. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada. Address: 100 King Street West, Toronto, ON, Canada, M5X 1C9
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service